3 Biotech Stocks on Track for 50% Returns (or More) by 2028
The biotech industry, often recognized for its rapid innovation, can set investors up for outsized returns in the stock market. However, not all biotech companies have the capability of doing so.
Gildan Is Back On Track And Has Good Plans, The Stock Is Fairly Valued
Gildan Activewear Inc.'s Q2 2024 results were positive, with expected growth and increased market share. The company has levers to solidify its leading market position in the industry. Hold rating on the stock has been maintained since March 2024, with a positive outlook for future performance.
This Semiconductor Stock Is ON Track for a New High
Onsemi's NASDAQ: ON Q2 results were no blowout. Still, its operational quality and outlook for success have the stock price in rebound mode, and the market is on track to hit a one-year high soon.
After A Two-Year Slump, Shoe Carnival Is Back On Track For Growth
Shoe Carnival, Inc. is turning around its fortunes with Q1 of fiscal 2024 being a pivotal point. The company is launching initiatives to grow the business and constrain costs, and they are expected to lead to 6% earnings growth. Shoe Carnival has a competitive advantage in the retail footwear business, with a focus on customer experience.
Amid Q2 Earnings, Verizon Stock Needs to Do This 1 Thing to Get Back on Track
Verizon holds $149 billion in total debt. A low P/E ratio has offered investors little relief.
Enel Is On Track To Meet Top Range Outlook
The company's solid operating growth, cost-saving initiatives, and disposal program support a positive outlook for shareholders. A positive rating credit update and a better FCF generation in H2 will support Enel's re-rating. Enel's valuation remains attractive compared to EU and global peers, with a target price of €8.3 per share based on a 12x P/E multiple.
Texas Instruments on Track for Growth, Recovery in Key Markets And More: Analyst
JP Morgan analyst Harlan Sur reiterated an Overweight rating on Texas Instruments Inc TXN with a price target of $230, up from $195.
Tiziana Life Sciences secures FDA Fast Track status for MS therapy intranasal foralumab
Tiziana Life Sciences Ltd (NASDAQ:TLSA) shares moved higher after the biotechnology firm revealed the US Food and Drug Administration (FDA) has granted Fast Track designation to its intranasal formulation of foralumab for the treatment of non-active Secondary Progressive Multiple Sclerosis. The FDA's Fast Track designation is intended to support the development of and review of drugs that address an unmet medical need.
United Parcel Service Stock on Track for Worst Day Ever
United Parcel Service, Inc. (NYSE:UPS) stock is 11.3% lower to trade at $128.74 this morning, after the shipping name's second-quarter earnings and revenue miss, as well as its lowered fiscal-year revenue guidance.
Post Holdings: Expansion Into Pet Food Continues Great M&A Track Record
Post Holdings has a great track record of strategic M&A where the company expands the acquired businesses accretively, while the organic performance is overall stable. The expansion into pet food marks Post Holdings' newest continuation of the story with two reasonably priced acquisitions. Earnings turbulence should be expected due to a recent Influenza outbreak, but the turbulence shouldn't disturb the long-term strategy and earnings.
Berkshire's Future: Greg Abel's Impressive Track Record
Greg Abel will be the main decision-maker driving Berkshire's future growth. Berkshire Hathaway Energy, managed by Greg Abel, has been the fastest organically growing division of Berkshire. Greg Abel has been deploying capital at ~13% return, exceeding even Warren Buffett's stock portfolio returns.
Is Solana on Track to Hit $200 by 2025?
Is Solana on track for a major price surge? See how it compares to Ethereum and other rivals.
